Trial Profile
Teriparatide in postmenopausal women with osteoporosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jul 2012
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Fracture; Menopause; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms FPT
- 01 Jun 2012 Substudy results published in Bone.
- 05 Nov 2010 New trial record.